From startups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.

An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…

Eli Lilly

Merck halts Alzheimer’s phase 3 after interim data analysis

Lilly to ax 200 R&D positions globally

Lilly buys migraine biotech CoLucid, and the drug it outlicensed, for $960M

After phase 3 failures, Lilly signs new Alzheimer’s drug pact with AstraZeneca

Analysts on amyloid thesis: It's not dead yet

Neurimmune, TVM set up ALS biotech, secure support of Eli Lilly unit for advance toward clinical proof of concept

Alzheimer's hopes dashed as Lilly gives up on amyloid drug solanezumab

Janssen seeks FDA approval for IL-23 blockbuster hopeful guselkumab